Zobrazeno 1 - 10
of 119
pro vyhledávání: '"N. Bijker"'
Autor:
E.G. Engelhardt, R.S.J.M. Schmitz, M.A. Gerritsma, C.M.T. Sondermeijer, E. Verschuur, J.H.E. Houtzager, R. Griffioen, N. Bijker, R.M. Mann, V. Retèl, F.H. van Duijnhoven, J. Wesseling, E.M.A. Bleiker, Alastair Thompson, Serena Nik-Zainal, Elinor J. Sawyer, Helen Davies, Andrew Futreal, Nicholas Navin, E. Shelley Hwang, Jos Jonkers, Jacco van Rheenen, Fariba Behbod, Esther H. Lips, Marjanka Schmidt, Lodewyk F.A. Wessels, Daniel Rea, Proteeti Bhattacharjee, Hilary Stobart, Deborah Collyar, Donna Pinto, Marja van Oirsouw, S. Alaeikhanehshir, L. Elshof
Publikováno v:
Breast, Vol 77, Iss , Pp 103764- (2024)
Background: Ductal carcinoma in situ (DCIS) can progress to invasive breast cancer (IBC), but often never will. As we cannot predict accurately which DCIS-lesions will or will not progress to IBC, almost all women with DCIS undergo breast-conserving
Externí odkaz:
https://doaj.org/article/bc84270199394f7bb7028854a77ee924
Autor:
D.B. Raphael, N.S. Russell, B. Winkens, J.M. Immink, P.G. Westhoff, M.C. Stenfert Kroese, M.R. Stam, N. Bijker, C.M.J. van Gestel, T. van der Weijden, L.J. Boersma
Publikováno v:
Technical Innovations & Patient Support in Radiation Oncology, Vol 20, Iss , Pp 1-9 (2021)
Background and Purpose: In selected breast cancer patients, radiation treatment (RT) lowers the recurrence risk, with minor or no improvement of survival. In these patients, the choice to undergo RT is considered a preference-sensitive decision. To f
Externí odkaz:
https://doaj.org/article/1d9eef29b37c4c679337fae9d254ae42
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Koen Crama, N. Bijker, Maurice J.C. van der Sangen, Tonnis Nuver, Liesbeth J. Boersma, Coen W. Hurkmans, Cindy Duisters, K. Verhoeven, Mieke Peters-Verhoeven
Publikováno v:
Technical Innovations & Patient Support in Radiation Oncology
Technical Innovations and Patient Support in Radiation Oncology, 19, 26-32. Elsevier
Technical Innovations & Patient Support in Radiation Oncology, Vol 19, Iss, Pp 26-32 (2021)
Technical Innovations and Patient Support in Radiation Oncology, 19, 26-32. Elsevier Ireland Ltd
Technical Innovations and Patient Support in Radiation Oncology, 19, 26-32. Elsevier
Technical Innovations & Patient Support in Radiation Oncology, Vol 19, Iss, Pp 26-32 (2021)
Technical Innovations and Patient Support in Radiation Oncology, 19, 26-32. Elsevier Ireland Ltd
Highlights • Results of a breast cancer planning study with 4 cases conducted in the Netherlands are reported. • A guideline for evaluation of breast cancer radiotherapy treatment plans has been established. • The dosimetric parameters D98%, Dm
Autor:
R. Schmitz, C. Sondermeijer, V. van der Noort, E. Engelhardt, M. Gerritsma, E. Verschuur, M. van Oirsouw, E. Bleiker, N. Bijker, R. Mann, F. van Duijnhoven, J. Wesseling
Publikováno v:
European Journal of Cancer. 175:S3-S4
Autor:
Nansi Maliko, Eline KleinJan, Marie-Jeanne T. F. D. Vrancken Peeters, M. Essers, Michel W.J.M. Wouters, Maurice Mulder, Liesbeth J. Boersma, Coen W. Hurkmans, Marcel R Stam, N. Bijker
Publikováno v:
Radiation Oncology, 17(1):73. BioMed Central Ltd
Radiation Oncology, 17(1). BMC
Radiation oncology (London, England), 17(1):73. BioMed Central
Radiation Oncology, 17(1). BMC
Radiation oncology (London, England), 17(1):73. BioMed Central
Background Radiotherapy (RT) is part of the curative treatment of approximately 70% of breast cancer (BC) patients. Wide practice variation has been reported in RT dose, fractionation and its treatment planning for BC. To decrease this practice varia
Autor:
N. Bijker, Nicola S. Russell, D.B. Raphael, Liesbeth J. Boersma, C. M. J. van Gestel, M.C. Stenfert Kroese, T. van der Weijden, M.R. Stam, P.G. Westhoff, Bjorn Winkens, J. M. Immink
Publikováno v:
Technical Innovations & Patient Support in Radiation Oncology
Technical Innovations & Patient Support in Radiation Oncology, 20, pp. 1-9
Technical Innovations & Patient Support in Radiation Oncology, 20, 1-9
Technical Innovations and Patient Support in Radiation Oncology, 20, 1-9. Elsevier Ireland Ltd
Technical Innovations and Patient Support in Radiation Oncology, 20, 1-9. Elsevier
Technical Innovations & Patient Support in Radiation Oncology, Vol 20, Iss, Pp 1-9 (2021)
Technical Innovations & Patient Support in Radiation Oncology, 20, pp. 1-9
Technical Innovations & Patient Support in Radiation Oncology, 20, 1-9
Technical Innovations and Patient Support in Radiation Oncology, 20, 1-9. Elsevier Ireland Ltd
Technical Innovations and Patient Support in Radiation Oncology, 20, 1-9. Elsevier
Technical Innovations & Patient Support in Radiation Oncology, Vol 20, Iss, Pp 1-9 (2021)
Highlights • No difference was found in decisional conflict with or without PtDA use. • Patients who used the PtDA had more knowledge, suggesting a better informed choice. • Patients who used the PtDA chose more often for a less intensive treat
Autor:
Sabine Siesling, Henk Struikmans, Philip Poortmans, T. van Dalen, John H. Maduro, Pauline E. R. Spronk, K. Schreuder, N. Bijker
Publikováno v:
Clinical oncology, 31(4), 250-259. W.B. Saunders Ltd
Clinical oncology (Royal College of Radiologists (Great Britain)), 31(4), 250-259. W.B. Saunders Ltd
Clinical Oncology, 31(4), 250-259. ELSEVIER SCIENCE LONDON
Clinical oncology (Royal College of Radiologists (Great Britain)), 31(4), 250-259. W.B. Saunders Ltd
Clinical Oncology, 31(4), 250-259. ELSEVIER SCIENCE LONDON
Aims: To determine the variation in radiation therapy boost use in a nationwide study following adjustment of a national guideline in 2011, as well as to address the relationship to patient, tumour and radiation therapy institutional factors.Material
Publikováno v:
European Journal of Cancer, 138. Elsevier Limited
Publikováno v:
European Journal of Cancer, 138. Elsevier Limited